Later management of documented ischaemic heart disease: secondary prevention and rehabilitation.
Patients may present with a variety of syndromes related to ischaemic heart disease. These include unstable or stable angina pectoris, acute myocardial infarction, and occasionally cardiac failure without prior anginal pain or infarction. For the purposes of this review, it will generally be assumed that the condition has been stabilised, though one important aspect of the rehabilitation process is the recognition of continuing or recurrent problems such as angina pectoris and cardiac decompensation. This should then be followed by appropriate intervention. The key components of post-hospital management of such patients are: (i) support; (ii) education; (iii) assessment; (iv) intervention (if necessary); (v) therapy; and (vi) lifestyle modification.
McLeod
A A
AA
Department of Cardiology, Poole Hospital NHS Trust, Poole, UK.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000428:Alcohol Drinking; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000975:Antioxidants / Q000008:administration & dosage; D023903:Coronary Restenosis / Q000517:prevention & control; D005081:Exercise Therapy; D006333:Heart Failure / Q000188:drug therapy; D006801:Humans; D017202:Myocardial Ischemia / Q000517:prevention & control* / Q000523:psychology / Q000534:rehabilitation; D010349:Patient Compliance; D010353:Patient Education as Topic; D010840:Phytosterols / Q000008:administration & dosage; D018570:Risk Assessment; D016540:Smoking Cessation; D012944:Social Support; D015912:Thrombolytic Therapy; D015431:Weight Loss
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000975:Antioxidants; D010840:Phytosterols